Free cash flow (OCF − capex)
Flow – sum over the period · $M
Q4 2019
44a$M
derived
All values (42)
| Period | Value ($M) | Status |
|---|---|---|
| Q2 2026 | 967 | derived |
| Q1 2026 | 935 | derived |
| Q4 2025 | 580 | derived |
| Q3 2025 | 1,400 | derived |
| Q2 2025 | 343 | derived |
| Q1 2025 | 101 | derived |
| Q4 2024 | −13 | derived |
| Q3 2024 | 628 | derived |
| Q2 2024 | 481 | derived |
| Q1 2024 | 457 | derived |
| Q4 2023 | −850 | derived |
| Q3 2023 | 453 | derived |
| Q2 2023 | 84 | derived |
| Q1 2023 | 262 | derived |
| Q4 2022 | −4 | derived |
| Q3 2022 | −21 | derived |
| Q2 2022 | −159 | derived |
| Q1 2022 | 188 | derived |
| Q4 2021 | 158 | derived |
| Q3 2021 | 376 | derived |
| Q2 2021 | 243 | derived |
| Q1 2021 | −63 | derived |
| Q4 2020 | −140 | derived |
| Q3 2020 | 383 | derived |
| Q2 2020 | −304 | derived |
| Q1 2020 | 95 | derived |
| Q4 2019 | 44 | derived |
| Q3 2019 | 223 | derived |
| Q2 2019 | 121 | derived |
| Q1 2019 | 14 | derived |
| Q4 2018 | 152 | derived |
| Q3 2018 | 34 | derived |
| Q2 2018 | 4 | derived |
| Q1 2018 | 44 | derived |
| Q4 2017 | −9 | derived |
| Q3 2017 | 34 | derived |
| Q2 2017 | 39 | derived |
| Q1 2017 | 37 | derived |
| Q4 2016 | −6 | derived |
| Q3 2016 | 52 | derived |
| Q2 2016 | −27 | derived |
| Q1 2016 | −21 | derived |
CSV with all sources · Technical ID: fcf
Free cash flow = operativer Cashflow (ocf) − Investitionen in Sachanlagen (capex), beide per Kapitalflussrechnung im SEC-Filing; derived, keine firmeneigene Non-GAAP-Definition (Meta/Microsoft/Tesla definieren FCF teils abweichend).
More metrics for Block
Income statement
Balance sheet
Debt and interest
Revenue by segment/product/region
Gross profit by segment
Sources & calculation
- Value
- $44.0M (derived)
- Period
- Q4 2019, ended Dec 31, 2019 · quarterly value (3 months, not cumulative)
- Calculation
- FCF = OCF $61.0M − Capex $17.0M = $44.0M (OCF: 10-K 0001512673-21-000008 filed Feb 23, 2021; Capex: 10-K 0001512673-21-000008 filed Feb 23, 2021; Formel einheitlich, not die firmeneigene Non-GAAP-Definition; Einheit USD)
- Source
- 10-K, filed Feb 23, 2021 · 0001512673-21-000008
- Confidence
- 0.95 – berechnet aus berichteten SEC-Werten derselben Periode (e.g. SG&A = S&M + G&A)
- Basis
- Basis-Note: quarter auf früherer Basis; of the aktuelle GJ-Wert (265M, 10-K filed Feb 24, 2022) ist neu gegliedert. sum Q1–Q4 = 403M = frühere GJ-Fassung.
Versions
| v1 | $44.0M | Feb 23, 2021 | 10-K 0001512673-21-000008 | derived · confidence 0.95 · current |